Sonendo Announces Launch of Second Generation CleanFlow™ Procedure Instrument for Heightened Efficacy and Ease of Use

Rhea-AI Impact
Rhea-AI Sentiment
(Very Positive)
Rhea-AI Summary
Sonendo, Inc. launches second generation CleanFlow Procedure Instrument for improved root canal treatment. The optimized design and enhanced matrix system provide a heightened level of consistency, simplifying the treatment process for clinicians. The new instrument can be used on all teeth, reducing the need for multiple instruments. The GentleWave System with CleanFlow Technology offers effective and efficient treatment with little to no post-treatment pain and rapid healing rates.
  • None.
  • None.

The new enhanced procedure instrument is designed for improved sealing and increased procedural consistency to elevate root canal treatment for clinicians and their patients

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of its second generation CleanFlow™ Procedure Instrument. The updated procedure instrument now includes an optimized design and enhanced matrix system to improve the effectiveness and ease of use of the GentleWave Procedure. This redesigned matrix facilitates a more congruent, secure and lasting seal which provides a heightened level of consistency, further simplifying the root canal treatment process for clinicians and improving the overall patient experience. Combined with its optimized design, these changes now allow doctors to use one procedure instrument for all teeth.

“The CleanFlow Procedure Instrument with the new matrix has been unparalleled in consistency and ease of use,” said Dr. Luis Missura of Precision Endodontics. “The GentleWave Procedure gives reliable, comfortable, uncompromising disinfection that yields some of the best clinical results I’ve seen.”

Last month, Sonendo announced that its CleanFlow Procedure Instrument is now indicated for use on anterior teeth, replacing its legacy APM (Anterior Pre-Molar) Procedure Instrument. This indication, along with the new matrix system and optimized design, underscores Sonendo’s commitment to ongoing product refinement and innovation and continued investment in improving both the clinician and patient experience.

“Our top priority is our partner clinicians and their patients, so we are pleased to announce further enhancements and the launch of our second generation CleanFlow Procedure Instrument,” said Michael Smith, chief commercial officer of Sonendo. “Our goal is to help clinicians navigate the challenges of root canal therapy and provide exceptional patient care. We are confident this optimized design and enhanced matrix is the final step towards our goal of simplifying our portfolio through one procedure instrument.”

The GentleWave System is the only FDA-cleared system for root canal procedures that employs a sterilized, single-use procedure instrument to automate the cleaning and disinfection of microscopic spaces within root canals. Now, the CleanFlow Procedure Instrument is the only procedure instrument needed for the GentleWave System to treat all teeth.

The GentleWave System with CleanFlow Technology is designed for both clinicians and patients, enabling one-handed procedures and a more effective and efficient root canal treatment and offering little to no post-treatment pain and rapid healing rates. For more information on the GentleWave System, visit

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. Sonendo is also the parent company of TDO Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.

For more information on Sonendo, visit For more information on the GentleWave System, visit


Macy Hyland

Crowe PR

Source: Sonendo, Inc.

Sonendo Inc


SONX Rankings

SONX Latest News

SONX Stock Data

Surgical and Medical Instrument Manufacturing

About SONX

sonendo®, inc. is a privately held, venture-backed company developing innovative technologies to save teeth through sound science®. sonendo’s multisonic ultracleaning™ technology is elevating the level of clean throughout endodontics and dentistry. by introducing broad spectrum acoustic technology, sonendo is helping to reduce doctors’ reliance on standard instrumentation while saving teeth¹ and changing patients’ lives. after years of research and development, sonendo’s gentlewave® system presents an entirely new way of thinking about root canal therapy. using closed-loop, multisonic ultracleaning technology, the gentlewave system reaches deep into the lateral canals and microscopic tubules of the root canal system to remove tissue, debris, biofilm and bacteria.² ³ your practice can offer unprecedented cleaning with the gentlewave system. sonendo investors include cvf, llc, dinova capital, fjord ventures, meritech capital partners, neomed management, orbimed advisors llc, seb private